how big is Espire Hospi?

As of Jun 06, Espire Hospitality Ltd has a market capitalization of 694.00 Cr, with recent net sales of 118.75 Cr and a net profit of 8.27 Cr. Shareholder's funds are valued at 3.31 Cr, and total assets amount to 69.51 Cr.

Market Cap: As of Jun 06, Espire Hospitality Ltd has a market capitalization of 694.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported Net Sales of 118.75 Cr and a Net Profit of 8.27 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: This is also based on Standalone data for the latest annual period ending in Mar'24. The Shareholder's Funds are valued at 3.31 Cr, while the Total Assets amount to 69.51 Cr.

What does Espire Hospi do?

Espire Hospitality Ltd operates in the Hotels & Resorts industry, reporting net sales of 41 Cr and a net profit of 4 Cr for the quarter ending March 2025. The company, with a market cap of Rs 701 Cr, has a P/E ratio of 84.00 and a return on equity of 191.44%.

Overview:<BR>Espire Hospitality Ltd operates in the Hotels & Resorts industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Incorporated in October 1991, Espire Hospitality Ltd was formerly known as Wellesley Corporation Limited. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 41 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 4 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 701 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 84.00 <BR>Industry P/E: 33 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 17.16 <BR>Return on Equity: 191.44% <BR>Price to Book: 160.97<BR><BR>Contact Details:<BR>Address: Shop No 1 Country Inn, Mehragaon Bhimtal UTT : 248179 <BR>Tel: 91-011-2618 4535/2618 4411 <BR>Email: investor@wellesleycorp.com <BR>Website: http://www.espirehospitality.com

Has Espire Hospi declared dividend?

No Dividend History Available

Who are the peers of the Espire Hospi?

Espire Hospi's peers include Indian Hotels Co, ITC Hotels, EIH, Chalet Hotels, Ventive Hospital, Advani Hotels, The Byke Hospi, Sinclairs Hotels, Sayaji Hotels, and Phoenix Township. Espire Hospi has a below-average management risk and a 1-year return of 300.58%, the highest among its peers.

Peers: The peers of Espire Hospi are Indian Hotels Co, ITC Hotels, EIH, Chalet Hotels, Ventive Hospital, Advani Hotels, The Byke Hospi, Sinclairs Hotels, Sayaji Hotels, and Phoenix Township.<BR><BR>Quality Snapshot: Excellent management risk is observed at EIH and Sinclairs Hotels, while Average management risk is found at Indian Hotels Co and Advani Hotels. Below Average management risk is noted for Espire Hospi, Chalet Hotels, Ventive Hospital, The Byke Hospi, Sayaji Hotels, and Phoenix Township. Growth is rated as Excellent for Ventive Hospital, Good for Indian Hotels Co and EIH, Average for Espire Hospi, and Below Average for ITC Hotels, Chalet Hotels, Advani Hotels, The Byke Hospi, Sinclairs Hotels, and Sayaji Hotels. Capital Structure is Excellent for EIH and Advani Hotels, Good for The Byke Hospi, and Below Average for Espire Hospi, ITC Hotels, Chalet Hotels, Ventive Hospital, Sinclairs Hotels, and Sayaji Hotels.<BR><BR>Return Snapshot: Espire Hospi has a 1-year return of 300.58%, which is the highest among its peers, while Advani Hotels has the lowest at -11.04%. Espire Hospi's return significantly exceeds that of Advani Hotels. Additionally, the peers with negative six-month returns include EIH, Advani Hotels, Sinclairs Hotels, and Sayaji Hotels.

Who are in the management team of Espire Hospi?

As of March 2022, the management team of Espire Hospi includes Leela Rani Bisht (Director), Prithvi Raj Singh (Managing Director), Amit Rai (Director), Gagan Oberoi (Chairperson), Sumeer Narain Mathur (CFO & Company Secretary), and three Independent Directors: Pramod Bhatnagar, Dileep Kumar, and Amit Kumar Jain. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Espire Hospi includes the following individuals:<BR><BR>1. Leela Rani Bisht - Director<BR>2. Prithvi Raj Singh - Managing Director<BR>3. Amit Rai - Director<BR>4. Gagan Oberoi - Chairperson<BR>5. Sumeer Narain Mathur - CFO & Company Secretary<BR>6. Pramod Bhatnagar - Independent Director<BR>7. Dileep Kumar - Independent Director<BR>8. Amit Kumar Jain - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Who are the top shareholders of the Espire Hospi?

The top shareholders of Espire Hospi are primarily the promoters, with Mrs. Sadhana Rai holding 67.01%. Other significant shareholders include Rajesh Kumar Gupta at 6.96%, individual investors with 18.5%, and a foreign institutional investor with 2.08%.

The top shareholders of Espire Hospi include the promoters, with Mrs. Sadhana Rai holding the largest share at 67.01%. There are no pledged promoter holdings. Additionally, Rajesh Kumar Gupta is the highest public shareholder, owning 6.96%. The company also has individual investors holding a combined 18.5%, and there is one foreign institutional investor (FII) that holds 2.08%. Overall, the majority of the shares are held by the promoters.

Are Espire Hospi latest results good or bad?

Espire Hospitality's latest results show strong net sales growth of 172.78% to Rs 72.34 crore, but profitability has declined, with Profit After Tax down 30.8% and rising interest costs posing challenges. Overall, while sales performance is impressive, the company faces significant financial hurdles.

Espire Hospitality's latest results present a mixed picture. On one hand, the company achieved a remarkable year-on-year growth in net sales, reaching Rs 72.34 crore, which is a significant increase of 172.78%. This indicates strong market performance and demand for its services.<BR><BR>However, there are notable challenges as well. The Profit After Tax (PAT) for the quarter declined to Rs 1.43 crore, down 30.8% from the average PAT of Rs 2.07 crore over the previous four quarters. Similarly, the Profit Before Tax (PBT) also saw a decrease of 19.9%, falling to Rs 1.88 crore compared to the average PBT of Rs 2.35 crore in prior quarters. Additionally, the company has faced rising interest costs, with a 37.44% increase in interest expenses over the last six months.<BR><BR>Overall, while the sales growth is impressive, the declines in profitability and rising costs suggest that Espire Hospitality is facing some significant challenges that could impact its financial health moving forward.

When is the next results date for Espire Hospi?

Espire Hospi will announce its results on 14 November 2025.

Espire Hospi will declare its results on 14 November 2025.

How has been the historical performance of Espire Hospi?

Espire Hospi has shown significant growth from March 2022 to March 2025, with net sales increasing from 1.69 Cr to 119.55 Cr, and profitability improving with profit after tax rising to 8.27 Cr from a loss. The company's total assets and equity reserves also expanded notably during this period.

Answer:<BR>The historical performance of Espire Hospi shows significant growth in net sales and profitability over the years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Espire Hospi's net sales have increased dramatically from 1.69 Cr in March 2022 to 119.55 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar trajectory, reaching 119.55 Cr in March 2025, up from just 1.69 Cr in March 2022. The company has also improved its operating profit, which turned positive in March 2022 and rose to 23.08 Cr by March 2025. Profit before tax also saw a notable increase, moving from a mere 0.03 Cr in March 2022 to 10.81 Cr in March 2025, while profit after tax reached 8.27 Cr in March 2025, compared to a loss of 0.08 Cr in March 2022. The company's total assets grew significantly from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, reflecting a robust expansion. Total liabilities also increased, from 7.29 Cr in March 2022 to 181.20 Cr in March 2025, primarily driven by long-term borrowings which rose to 69.93 Cr. Despite the increase in liabilities, the company's equity capital and reserves improved, with reserves turning positive at 28.58 Cr in March 2025, up from negative values in previous years. Overall, Espire Hospi's financial performance indicates a strong growth trajectory with improving profitability and asset base.

Is Espire Hospi technically bullish or bearish?

As of November 17, 2025, the market trend is bearish with moderate strength, supported by bearish indicators from the MACD, moving averages, and Bollinger Bands, despite some bullish momentum in the RSI.

As of 17 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages confirm a bearish outlook. The weekly Bollinger Bands also indicate a bearish trend, while the KST is bearish on the weekly timeframe. Although the weekly RSI shows bullish momentum, it is not sufficient to counter the overall bearish indicators. The Dow Theory indicates no trend on the weekly level and mildly bearish on the monthly level, further supporting the bearish stance.

Should I buy, sell or hold Espire Hospi?

Is Espire Hospi overvalued or undervalued?

As of November 20, 2025, Espire Hospi is considered overvalued with a PE ratio of 169.37, significantly higher than its peers, and despite impressive long-term returns, it has recently underperformed compared to the Sensex.

As of 20 November 2025, the valuation grade for Espire Hospi has moved from very expensive to expensive, indicating a slight improvement but still suggesting high valuation concerns. The company is currently considered overvalued based on its elevated financial ratios, including a PE ratio of 169.37, an EV to EBITDA of 28.88, and a PEG ratio of 70.04, which are significantly higher than industry norms.<BR><BR>In comparison to its peers, Espire Hospi's PE ratio far exceeds that of JSW Steel at 46.74 and Tata Steel at 28.92, both of which are rated as fair and attractive, respectively. This stark contrast highlights the overvaluation of Espire Hospi in the current market. Additionally, while the company has shown impressive returns over the past few years, including a staggering 2495.27% over three years, its recent performance has lagged behind the Sensex, with a 1-month return of -22.85% compared to the Sensex's 1.50%.

Which are the latest news on Espire Hospi?

Why is Espire Hospi falling/rising?

As of 03-Dec, Espire Hospitality Ltd's stock price is at 228.00, reflecting a significant decline of -45.45% over the last 13 days. The stock's poor performance is attributed to financial instability, low management efficiency, and a high debt-to-equity ratio, leading to negative investor sentiment despite increased trading volume.

As of 03-Dec, Espire Hospitality Ltd's stock price is falling, currently at 228.00, reflecting a change of -2.05 (-0.89%). The stock has been on a downward trend, losing value for the last 13 consecutive days, with a significant decline of -45.45% during this period. Today, it opened with a loss of -4.37% and reached an intraday low of Rs 218.55, which is a decrease of 5%.<BR><BR>The stock's performance over the past week shows a drastic decline of -17.81%, while it has fallen -46.00% over the past month, contrasting sharply with the Sensex, which has gained 1.34% in the same timeframe. Year-to-date, the stock is down -31.54%, while the Sensex has risen by 8.92%. Despite a positive return of 15.15% over the past year, the overall trend indicates significant struggles, particularly in recent weeks.<BR><BR>Factors contributing to this decline include poor management efficiency, as indicated by a low Return on Capital Employed (ROCE) of 4.26%, and a high Debt to Equity ratio of 8.60 times, which suggests financial instability. Additionally, the company's recent financial performance has been concerning, with a quarterly profit after tax (PAT) of -5.71 crore, representing a drastic fall of -336.2% compared to the previous four-quarter average. This has led to a negative operating profit to interest ratio, further exacerbating investor concerns.<BR><BR>While there has been a rise in investor participation, with delivery volume increasing by 111.59% against the 5-day average, the overall sentiment remains negative due to the company's financial challenges and declining stock performance. Thus, the combination of consecutive losses, poor financial metrics, and high debt levels are key reasons for the stock's current downward trajectory.